Nanodiamonds Inhibit Cancer Cell Migration by Strengthening Cell Adhesion: Implications for Cancer Treatment.
Qingyue GuoLei LiGuanyue GaoRunze LiuYasuaki EinagaJinfang ZhiPublished in: ACS applied materials & interfaces (2021)
Nanodiamonds (NDs) are a type of biocompatible nanomaterial with easily modified surfaces and are considered as promising candidates in biomedicine. In this work, the inhibition of tumor cell migration by carboxylated nanodiamonds (cNDs) was investigated. AFM-based single cell adhesion and F-actin staining experiments demonstrated that cNDs treatment could enhance cell adhesion and impair assembly of the cytoskeleton. The mechanism analysis of the regulatory protein expression level also proved that cNDs could inhibit the migration of Hela cells by preventing the epithelial-mesenchymal transition (EMT) process through the transforming growth factor β (TGF-β) signaling pathway. The in vivo pulmonary metastasis model also showed that cNDs effectively reduced the metastasis of murine B16 melanoma cells. In summary, cNDs have been demonstrated to inhibit cancer cell migration in vitro and decrease tumor metastasis in vivo. Therefore, cNDs might have potential utility for specific cancer treatment.
Keyphrases
- cell migration
- cell adhesion
- epithelial mesenchymal transition
- transforming growth factor
- signaling pathway
- papillary thyroid
- induced apoptosis
- cell cycle arrest
- squamous cell
- pi k akt
- atomic force microscopy
- pulmonary hypertension
- lymph node metastasis
- high speed
- oxidative stress
- squamous cell carcinoma
- transcription factor
- escherichia coli
- combination therapy
- ionic liquid
- staphylococcus aureus
- biofilm formation
- drug release
- risk assessment
- cystic fibrosis